ArticlePharmaceutical research2019

A Sialylated-Bortezomib Prodrug Strategy Based on a Highly Expressed Selectin Target for the Treatment of Leukemia or Solid Tumors.

Mingqi Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.